Association of angiotensin-converting enzyme gene 2350g>a polymorphism with myocardial infarction in a chinese population

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 4, 2009, Pages 435-442

  Min Pan, ^a   Jiang, Min Hui ^a   Wei, Mei Fang ^a   Liu, Zhi Hua ^a   Jiang, Wen Ping ^a   Geng, Hai Hua ^a   Cui, Zhi Chu ^b   Zhang, Dong Lei ^b   Zhu, Jian Hua ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Chinese; Genetic polymorphism; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN; C REACTIVE PROTEIN; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE; LIPID;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 69749085936     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608316013     Document Type: Article

References (38)

1. American Heart Association. Heart Disease and Stroke Statistics-2003 Update. Dallas, TX: American Heart Association ; 2002.
2. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 ; 359: 641-644.
3. Hoit BD, Gilpin EA, Henning H., et al. Myocardial infarction in young patients: an analysis by age subsets. Circulation. 1986 ; 74: 712-721.
4. Beohar N., Damaraju S., Prather A., et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 1995 ; 43: 275-280.
5. Schuster H., Wienker TF, Stremmler U., Noll B., Steinmetz A., Luft FC An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol. 1995 ; 76: 601-603.
6. Wang XL, McCredie RM, Wilcken DE Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol. 1996 ; 16: 115-119.
7. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet. 2000 ; 355: 434-442.
8. Lindpaintner K., Pfeffer MA, Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med. 1995 ; 332: 706-711.
9. Alhenc-Gelas F., Richard JL, Courbon D., Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men; relationship to environmental and hormonal parameters. J Lab Clin Med. 1991 ; 117: 33-39.
10. Cambien F., Alhenc-Gelas F., Herbeth B., et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet. 1988 ; 43: 774-780.
11. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidylcarboxy peptidose 1). Nucleic Acids Res. 1992 ; 20: 1433.
12. Niu T., Chen X., Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease. Therapeutic implications. Drugs. 2002 ; 62: 977-993.
13. Levy D., DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from The Framingham Heart Study. Hypertension. 2000 ; 36: 477-483.
14. Zhu X., Bouzekri N., Southam L., et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001 ; 68: 1139-1148.
15. Harris PJ, Harrell FE Jr, Lee KL, Behar VS, Rosati RA Survival in medically treated coronary artery disease. Circulation. 1979 ; 60: 1259-1269.
16. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990 ; 82: 1193-1202.
17. Eda S., Kaufmann J., Roos W., Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal. 1998 ; 12: 137-144.
18. Miller SA, Dykes DD, Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 ; 16: 1215.
19. Cicoira M., Zanolla L., Rossi A., et al. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol. 2001 ; 37: 1808-1812.
20. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation. 2000 ; 102: 829-832.
21. Dzau VJ, Gibbons GH, Pratt RE Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension. 1991 ; 18 (4 suppl). 100-105.
22. Pratt RE Regulation of vascular smooth-muscle cell growth by angiotensin II. Blood Press Suppl. 1996 ; 2: 6-9.
23. Larsson PT, Schwieler JH, Wallen NH Platelet activation during angiotensin II infusion in healthy volunteers. Blood Coagul Fibrinolysis. 2000 ; 11: 61-69.
24. Touyz RM, Schiffrin EL Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. Hypertension. 1993 ; 22: 853-862.
25. He M., He X., Xie Q., Chen F., He S. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thromb Res. 2006 ; 117: 579-590.
26. Feener EP, Northrup JM, Aiello LP, King GL Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest. 1995 ; 95: 1353-1362.
27. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 ; 86: 1343-1346.
28. Andrikopoulos GK, Richter DJ, Needham EW, et al. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2004 ; 11: 477-483.
29. Iqbal MP, Mahmood S., Mehboobali N., et al. Association study of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with myocardial infarction. Exp Mol Med. 2004 ; 36: 110-115.
30. Arikan E., Sen S. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors. Clin Appl Thromb Haemostat. 2005 ; 11: 147-159.
31. Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five-year follow-up of the seven countries study. JAMA. 1995 ; 274: 131-136.
32. Neaton JD, Blackburn H., Jacobs D., et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med. 1992 ; 152: 1490-1500.
33. Andreotti F., Porto I., Crea F., Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart. 2002 ; 87: 107-112.
34. Paternoster DM, Fantinato S., Stella A., et al. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Haemostat. 2006 ; 12: 330-337.
35. Kinlay S., Schwartz GG, Olsson AG, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) Study. Circulation. 2004 ; 110: 386-391.
36. Nomura S., Shouzu A., Omoto S., Nishikawa M., Iwasaka T., Fukuhara S. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Haemostat. 2004 ; 10: 205-215.
37. Kubo T., Imanishi T., Takarada S., et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007 ; 50: 933-939.
38. Diet F., Pratt RE, Berry GJ, Momose N., Gibbons GH, Dzau VJ Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 1996 ; 94: 2756-2767.